These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4893831)

  • 1. Prevention of clinical and subclinical rubella infection. Efficacy of three HPV-77 derivative vaccines.
    Detels R; Grayston JT; Kim KS; Chen KP; Gale JL; Beasley RP; Gutman L
    Am J Dis Child; 1969 Aug; 118(2):295-300. PubMed ID: 4893831
    [No Abstract]   [Full Text] [Related]  

  • 2. Viral shedding in Chinese children following vaccination with HPV-77 and Cendehill-51 live attenuated rubella vaccines.
    Detels R; Kim KS; Gale JL; Grayston JT
    Am J Epidemiol; 1971 Nov; 94(5):473-8. PubMed ID: 4941155
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of rubella during an epidemic on Taiwan. HPV-77 and RA 27-3 rubella vaccines administered subcutaneously and intranasally HPV-77 vaccine mixed with mumps and-or measles vaccines.
    Beasley RP; Detels R; Kim KS; Gale JL; Lin TL; Grayston JT
    Am J Dis Child; 1969 Aug; 118(2):301-6. PubMed ID: 4893832
    [No Abstract]   [Full Text] [Related]  

  • 4. Field trial of live attenuated rubella virus vaccine during an epidemic on Taiwan. Preliminary report of efficacy of three HPV-77 strain vaccines in the prevention of clinical rubella.
    Grayston JT; Detels R; Chen KP; Gutman L; Kim KS; Gale JL; Beasley RP
    JAMA; 1969 Feb; 207(6):1107-10. PubMed ID: 4884671
    [No Abstract]   [Full Text] [Related]  

  • 5. Children immunized with HPV-77 rubella vaccine. Additional laboratory observations.
    Katz SL; Lang DJ; Wilfert CM; Feigin RD; Goldfein M
    Am J Dis Child; 1969 Aug; 118(2):213-7. PubMed ID: 4893822
    [No Abstract]   [Full Text] [Related]  

  • 6. Rubella virus vaccine (HPV-77-DE 5). Antigenic and protective efficacy in a community trial.
    McCollum RW; Randolph MF; Byrne EB; Hilleman MR
    Am J Dis Child; 1969 Aug; 118(2):186-9. PubMed ID: 4893821
    [No Abstract]   [Full Text] [Related]  

  • 7. A study of rubella immunity and resistance to infection.
    Davis WJ; Larson HE; Simsarian JP; Parkman PD; Meyer HM
    JAMA; 1971 Jan; 215(4):600-8. PubMed ID: 5107436
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccination of infants with HPV-77 vaccine.
    Pavilanis V; Chagnon A; Davignon L; Joncas J
    Am J Dis Child; 1969 Aug; 118(2):247-51. PubMed ID: 4978509
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental rubella studies. I. Clinical and laboratory features of infection caused by the Brown strain rubella virus. II. Artificial challenge studies of adult rubella vaccinees.
    Schiff GM; Donath R; Rotte T
    Am J Dis Child; 1969 Aug; 118(2):269-74. PubMed ID: 5802433
    [No Abstract]   [Full Text] [Related]  

  • 10. Attenuated rubella virus vaccines in children with tuberculosis. Clinical trials.
    Boué A; Celers J
    Am J Dis Child; 1969 Aug; 118(2):258-60. PubMed ID: 4893827
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and serologic studies of an outbreak of rubella in a vaccinated population.
    Chang TW; DesRosiers S; Weinstein L
    N Engl J Med; 1970 Jul; 283(5):246-8. PubMed ID: 5424733
    [No Abstract]   [Full Text] [Related]  

  • 12. Reinfection with rubella virus despite live vaccine induced immunity. Trials of HPV-77 and HPV-80 live rubella virus vaccines and subsequent artificial and natural challenge studies.
    Wilkins J; Leedom JM; Portnoy B; Salvatore MA
    Am J Dis Child; 1969 Aug; 118(2):275-94. PubMed ID: 5794818
    [No Abstract]   [Full Text] [Related]  

  • 13. Attenuated rubella viruses. Laboratory and clinical characteristics.
    Meyer HM; Parkman PD; Hobbins TE; Larson HE; Davis WJ; Simsarian JP; Hopps HE
    Am J Dis Child; 1969 Aug; 118(2):155-65. PubMed ID: 4978508
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical evaluation of rubella vaccine, Cendehill strain.
    Farquhar JD
    South Med J; 1970 Apr; 63(4):371-5. PubMed ID: 4908607
    [No Abstract]   [Full Text] [Related]  

  • 15. An open community trial of live rubella vaccines. Study of vaccine virus transmissibility and antigenic efficacy of three HPV-77 derivatives.
    Veronelli JA
    JAMA; 1970 Sep; 213(11):1829-36. PubMed ID: 4917635
    [No Abstract]   [Full Text] [Related]  

  • 16. Artificial challenge studies in rubella. Utilization of RA 27-3 rubella vaccines, rubella naturally acquired seropositives, and rubella susceptible children.
    Naficy K; Nategh R; Ahangary S; Mohsenin H
    Am J Dis Child; 1970 Dec; 120(6):520-3. PubMed ID: 5481902
    [No Abstract]   [Full Text] [Related]  

  • 17. Rubella vaccines.
    Lancet; 1970 Jan; 1(7638):127-8. PubMed ID: 4188730
    [No Abstract]   [Full Text] [Related]  

  • 18. Attenuated rubella vaccine (HPV-77): evaluation in a large controlled trial.
    Lipman RP; Bethel MB; Wooten JH; Levine RH; Pagano JS
    Am J Public Health; 1971 Jul; 61(7):1392-402. PubMed ID: 4935166
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental active and passive immunization against rubella.
    Budai J; Tóth M; Melis L
    Acta Paediatr Acad Sci Hung; 1970; 11(3):209-17. PubMed ID: 4111953
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunologic response, virus excretion, and joint reactions with rubella vaccine. A study of adolescent girls and young women given live attenuated virus vaccine (HPV-77:DE-5).
    Lerman SJ; Nankervis GA; Heggie AD; Gold E
    Ann Intern Med; 1971 Jan; 74(1):67-73. PubMed ID: 4923805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.